Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01551797 · ClinicalTrials.gov registry record · Phase 1
A Pharmacokinetic Study to Compare Sustained Release and Standard Paracetamol Formulations.
A Phase 1 study of Pain, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT01551797 is a Phase 1 study of Pain that has completed, run by GlaxoSmithKline. The registered enrollment target is 14 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01551797, a Phase 1 study of Pain, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This proof of principle study will evaluate an experimental formulation of paracetamol that is being developed for eventual long lasting use. This study is also used for drug safety evaluation.
Conditions Studied
Interventions
- DRUG Paracetamol 500 mg
- DRUG Paracetamol 1000 mg
- DRUG Paracetamol 750 mg
Study Locations (1)
Washington
- Charles River Clinical Services Northwest, Inc. - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2010-05 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01551797
The ClinicalTrials.gov registry entry for NCT01551797 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (95% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 3 interventions - of which Paracetamol 500 mg is the first listed.
NCT01551797 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT01551797 about?
NCT01551797 is a clinical study titled "A Pharmacokinetic Study to Compare Sustained Release and Standard Paracetamol Formulations.". This proof of principle study will evaluate an experimental formulation of paracetamol that is being developed for eventual long lasting use. This study is also used for drug safety evaluation.
What is the current status of trial NCT01551797?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2010-05. Estimated completion is 2010-10.
What conditions does trial NCT01551797 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT01551797?
The interventions under investigation include: Paracetamol 500 mg (DRUG), Paracetamol 1000 mg (DRUG), Paracetamol 750 mg (DRUG).
Who is sponsoring clinical trial NCT01551797?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01551797 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
RECRUITING · Phase 1
-
Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants
RECRUITING · Phase 1
-
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery
RECRUITING · Phase 1
-
High Potency Cannabis: Acute and Protracted Effects
RECRUITING · Phase 1
-
Phase 1 Study of SBS-147 in Healthy Adults
RECRUITING · Phase 1
-
Patient Controlled Administration of Liquid Acetaminophen
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.